Pinnacle Associates’s Alder Biopharmaceuticals ALDR Stock Holding History

Pinnacle Associates’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-902,921	Closed	-$17M	–	753
2019 Q3	$17M	Buy	902,921 +52,120	+6%	+$596K	0.4%	68
2019 Q2	$10M	Sell	850,801 -70,303	-8%	-$851K	0.23%	120
2019 Q1	$12.6M	Sell	921,104 -5,963	-0.6%	-$77.3K	0.28%	97
2018 Q4	$9.5M	Sell	927,067 -55,162	-6%	-$706K	0.25%	115
2018 Q3	$16.4M	Sell	982,229 -142,956	-13%	-$2.58M	0.34%	82
2018 Q2	$17.8M	Sell	1,125,185 -175,625	-14%	-$2.67M	0.37%	79
2018 Q1	$16.5M	Sell	1,300,810 -47,820	-4%	-$692K	0.32%	86
2017 Q4	$15.4M	Buy	1,348,630 +138,550	+11%	+$1.55M	0.3%	89
2017 Q3	$14.8M	Buy	+1,210,080	New	+$12.6M	0.27%	97

Pinnacle Associates's ALDR Position: Q4 2019 in Review

Pinnacle Associates sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 902,921 shares — an estimated $17M sold.

Pinnacle Associates first reported a position in ALDR in Q3 2017 and held it in 9 quarters. The position peaked at $17.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Pinnacle Associates reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Pinnacle Associates sold 902,921 Alder Biopharmaceuticals shares in Q4 2019, an estimated $17M.
Pinnacle Associates first reported a position in Alder Biopharmaceuticals in Q3 2017 and held it in 9 quarters.
Pinnacle Associates's Alder Biopharmaceuticals position peaked at $17.8M in Q2 2018.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Pinnacle Associates's 13F filing for Q4 2019, filed 3 Feb 2020.